News

15 Analysts Assess KKR: What You Need To Know
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $136.8, a high ...
Assura Group Rejects KKR & Co. Inc. (KKR) Takeover Bid in Favor of Competitor $2.4 Billion Offer
KKR & Co. Inc. (NYSE:KKR) one of the best stocks in a Growth Stock Portfolio. Recently, on June 24, 2025, Assura Group, based ...
KKR to Sell Stake in Indian Pharma Company for $1.4 Billion
Private equity firm KKR has agreed to sell its entire stake in India-listed J.B. Chemicals & Pharmaceuticals for $1.4 billion. Under the deal, KKR will sell its 46.39% stake to Torrent Pharmaceuticals ...